Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER study

OBJECTIVE: EMPOwER, a double-blind, randomised, phase 3 study, evaluated the efficacy and safety of erenumab in adults with episodic migraine from Asia, the Middle East, and Latin America. METHODS: Randomised patients (N = 900) received monthly subcutaneous injections of placebo, erenumab 70 mg, or...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shuu-Jiun, Roxas, Artemio A, Saravia, Bibiana, Kim, Byung-Kun, Chowdhury, Debashish, Riachi, Naji, Tai, Mei-Ling Sharon, Tanprawate, Surat, Ngoc, Tai Tran, Zhao, Yi Jing, Mikol, Daniel D, Pandhi, Shaloo, Wen, Shihua, Mondal, Subhayan, Tenenbaum, Nadia, Hours-Zesiger, Peggy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592099/
https://www.ncbi.nlm.nih.gov/pubmed/34171973
http://dx.doi.org/10.1177/03331024211024160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592099/
https://www.ncbi.nlm.nih.gov/pubmed/34171973
http://dx.doi.org/10.1177/03331024211024160

Ejemplares similares